63
Participants
Start Date
May 31, 2011
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Seasonal Influenza Vaccine
This phase II is performed as a multicenter study in elderly subjects. Enrolled subjects received one single IM dose of trivalent subunit inactivated adjuvanted flu vaccine during the vaccination visit, according to the study protocol (follow-up period: until day 22) .
"Department of Scienze della Salute University of Genova Via Pastore 1", Genova
"Department of malattie infettive Ospedale San Gerardo, via Pergolesi 33", Monza
Vaccine and Immunotherapy Research Center Department of Infectious and Tropical Diseases San Raffaele Scientific Institute Via Stamira d'Ancona 20, Milan
"Satellite: ASL Lanciano - Vasto, sede legale Via S Spaventa 37", Lanciano
Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via Dei Vestini
"Satellite: Distretto Sanitario di Base di Fossacesia in Via Polidoro-Vasto", Lanciano
Lead Sponsor
Novartis Vaccines
INDUSTRY